Toggle light / dark theme

Tomorrow’s wars will be faster, more high-tech, and less human than ever before. Welcome to a new era of machine-driven warfare.

W allops Island —a remote, marshy spit of land along the eastern shore of Virginia, near a famed national refuge for horses—is mostly known as a launch site for government and private rockets. But it also makes for a perfect, quiet spot to test a revolutionary weapons technology.

If a fishing vessel had steamed past the area last October, the crew might have glimpsed half a dozen or so 35-foot-long inflatable boats darting through the shallows, and thought little of it. But if crew members had looked closer, they would have seen that no one was aboard: The engine throttle levers were shifting up and down as if controlled by ghosts. The boats were using high-tech gear to sense their surroundings, communicate with one another, and automatically position themselves so, in theory, .50-caliber machine guns that can be strapped to their bows could fire a steady stream of bullets to protect troops landing on a beach.

New weapons like hypersonic missiles are potentially reducing the amount of time that nuclear decision makers have to respond to an attack. Two US deterrence experts are proposing an artificial intelligence-based nuclear command, control, and communications system to ease this time pressure. It’s a risky solution.

The human body is an incredible machine. It is impossible to determine which is the essential body part for sustaining life — because there is no single indispensable part. If your heart stops beating, you will die. If your lungs stop working, your brain — and thus all of your cells — will eventually die. Without a stomach or intestines you cannot acquire nutrients and you will die. All parts are critical for optimal function, for sustaining life.

Synthetic biology as a field is no different. There are those that supply DNA — arguably the critical building block for every single synthetic biology application. There are those that automate and scale components of the design-build-test cycle to enable innovation to effect change in meaningful timelines. But when all of those parts come together with a single goal, the power of synthetic biology reaches new levels.

Such potential is exactly what Arzeda — through a collaboration with TeselaGen, Twist Bioscience, and Labcyte — has brought to us. Each company, a giant in its own right, provides an essential, needed component to an elegant, efficient workflow that can best be described as a “DNA assembly line” for more rapid, efficient protein design and production. The companies’ products work seamlessly: Twist produces the DNA fragments needed to make protein-expressing plasmids, Labcyte’s acoustic liquid handler (the Echo 525) facilitates rapid DNA assembly, and TeselaGen’s DNA assembly design and laboratory automation software connects the two, designing plasmids and ordering the necessary sequences from Twist while generating worklists for the Echo to execute.

Why the rush? It now costs $2.6 billion, by one estimate, to get a new drug to market, and pipelines are only getting slower and more expensive. There’s hope—and hype—that AI could help chip away at that figure by reducing the time and labor before a drug starts clinical trials. The idea is that the same techniques used to generate realistic deepfakes and deftly play Go might be able to decipher the complex rules of drug design and generate molecules from scratch.


Insilico Medicine is among several startups trying to harness artificial intelligence to speed to development of drugs.

A group of DARPA-funded scientists associated with Elon Musk say they’ve invented a new way to “rapidly implant” brain electrodes into rats — and their “sewing machine” implantation system could facilitate the creation of a mind-reading brain-computer interface, as first reported by Bloomberg.

“Although more research is needed to refine the overall interface system and better integrate its components, these developments may ultimately open the possibility of bundling next-generation robotics, AI software, and electronics to create alternatives to present-day neurosurgical techniques,” DARPA biotech director Justin Sanchez told Bloomberg.

Samsung is looking forward to what life might be like in the year 2069. The new report, called Samsung KX50: The Future in Focus, draws on the opinions of six of Britain’s leading academics and futurists to look at a range of new technologies that will affect people’s everyday lives.

Trying to predict the future is a dodgy business that has a notoriously low success rate. If the world of 2019 was anything like past predictions, we should have flying cars, personal jet packs, robot butlers, 100 percent atomic power producing limitless energy, little bottles containing nanobots that can grow cars on the front lawn, colonies on the Moon and Mars – and all in a society that hasn’t changed much since 1960, except it’s a bit nicer.

Could physics help people with epilepsy? That’s the question tackled by Louis Nemzer, a physicist at Nova Southeastern University, in the September 2019 issue of Physics World magazine, which is out now in print and digital formats.

He thinks that machine learning and real-time monitoring of the brain could give people with epilepsy live information about how much at risk they are of an imminent seizure – and is even developing a smartphone app to help them in daily life.

Elsewhere in the issue, Peter Martin and Tom Scott from the University of Bristol describe how they’ve used drones to map radiation levels at the Chernobyl plant, which you can also read on this website from 2 September, while Kate Brown from the Massachusetts Institute of Technology examines the health impact of Chernobyl fall-out.